Sarcouncil Journal of Engineering and Computer Sciences

Abstract: Pharmaceutical pricing transparency represents a critical challenge in contemporary healthcare economics, with significant implications for market efficiency, patient access, and system sustainability. The integration of artificial intelligence and blockchain technologies offers transformative potential to address longstanding issues of information asymmetry and pricing opacity throughout the pharmaceutical supply chain. These technologies provide unprecedented capabilities for real-time monitoring, analysis, and enforcement of ethical pricing practices across global markets. Artificial intelligence systems enable multi-dimensional data integration and anomaly detection while developing evidence-based ethical pricing models that balance innovation incentives with public health imperatives. Concurrently, blockchain implementations establish immutable transaction records throughout the supply chain, creating verifiable price histories that enhance accountability for all stakeholders. When integrated within regulatory frameworks, these technologies facilitate automated oversight with graduated response mechanisms that balance enforcement with appropriate market flexibility. The synergistic deployment of these digital solutions addresses fundamental market failures in pharmaceutical economics while promoting a more transparent, ethical, and equitable pricing ecosystem that benefits patients, providers, payers, and manufacturers alike. This technological framework represents a promising pathway toward resolving persistent tensions between pharmaceutical innovation and accessibility through enhanced transparency and data-driven decision-making.